Model
Edge
RVL Pharmaceuticals
0001767593
Filing Type
4
Filing Date
8/13/2023
Updated
8/14/23, 11:35 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership